Literature DB >> 15140602

The spectrum of antineuronal autoantibodies in a series of neurological patients.

M Vianello1, R Vitaliani, R Pezzani, P Nicolao, C Betterle, G Keir, E J Thompson, B Tavolato, F Scaravilli, B Giometto.   

Abstract

The aim of the present study is to identify the range of neurological disorders expressing antineuronal antibodies, evaluate the number of different patterns of reactivity that can be detected, and analyse the contribution of these studies to the identification of subgroups of patients. The records of 882 patients were reviewed and their sera and cerebrospinal fluids tested for antineuronal antibodies. Patients were initially divided into four groups according to suspected clinical diagnosis. Autoantibodies were detected by immunohistochemistry, Western blot of gradient-separated neuronal and recombinant proteins and by RIA. Cerebellar degeneration and sensory neuropathies were the most common neurological disorders in which paraneoplastic-related anti-neuronal antibodies were detected. However, in addition to PCA1/anti-Yo and ANNA1/anti-Hu antibodies, we found other reactivities in six patients with cerebellar degeneration: anti-GAD in three females and atypical in the other cases. The widest range of different anti-neuronal antibodies was detected in patients with peripheral sensory neuropathy. Few patients with Stiff-Person syndrome, temporal lobe epilepsy and myoclonus harboured anti-GAD antibodies. Atypical antibodies were detected in single cases with motor neuron disorder and multiple system atrophy. No anti-neuronal antibodies were detected in patients with neurological complications of connective tissue disorders other than Sjögren's syndrome, or in neurological diseases other than motor neuron disease and multiple system atrophy. Our study shows that the spectrum of neurological disorders in which anti-neuronal antibodies can be detected is wider than previously thought. In addition, we found patterns of neuronal staining and Western blot reactivity that differed from those so far reported. This may permit identification of subgroups of patients in whom strategies directed at removing and/or suppressing antibody production could be of some benefit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140602     DOI: 10.1016/j.jns.2004.01.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure.

Authors:  Richard Imrich; David S Goldstein; David M Jacobowitz
Journal:  Clin Auton Res       Date:  2006-09-14       Impact factor: 4.435

2.  Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease.

Authors:  Oliver Stich; Barbara Kleer; Sebastian Rauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-21       Impact factor: 10.154

3.  Neurological autoantibodies in drug-resistant epilepsy of unknown cause.

Authors:  Mehmet Tecellioglu; Ozden Kamisli; Suat Kamisli; Fatma Ebru Yucel; Cemal Ozcan
Journal:  Ir J Med Sci       Date:  2018-03-09       Impact factor: 1.568

4.  Neurological Disorders in Primary Sjögren's Syndrome.

Authors:  Gabriel J Tobón; Jacques-Olivier Pers; Valérie Devauchelle-Pensec; Pierre Youinou
Journal:  Autoimmune Dis       Date:  2012-03-05

5.  Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: Case report and discussion.

Authors:  Sarmad Said; Chad J Cooper; Edgar Reyna; Haider Alkhateeb; Jesus Diaz; Zeina Nahleh
Journal:  Am J Case Rep       Date:  2013-10-01

Review 6.  Paraneoplastic neurologic syndromes in children: a review article.

Authors:  Samin Alavi
Journal:  Iran J Child Neurol       Date:  2013

7.  Hypertrophic Pachymeningitis in Sjögren's Syndrome.

Authors:  Yumiko Nakano; Masayoshi Yamamoto; Kenichi Komatsu; Masato Yagita; Masaaki Fujita
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

8.  The management of adult patients with severe chronic small intestinal dysmotility.

Authors:  Jeremy M D Nightingale; Peter Paine; John McLaughlin; Anton Emmanuel; Joanne E Martin; Simon Lal
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

Review 9.  Paraneoplastic neurological syndromes.

Authors:  Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Orphanet J Rare Dis       Date:  2007-05-04       Impact factor: 4.123

10.  An update on the cerebellar subtype of multiple system atrophy.

Authors:  Ludovico Ciolli; Florian Krismer; Ferdinando Nicoletti; Gregor K Wenning
Journal:  Cerebellum Ataxias       Date:  2014-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.